ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,002,655 | +1.7% | 268,500 | -19.3% | 0.03% | +3.8% |
Q2 2023 | $129,741,117 | +140.1% | 332,900 | +129.5% | 0.03% | +136.4% |
Q1 2023 | $54,044,964 | -17.6% | 145,056 | -16.2% | 0.01% | -35.3% |
Q4 2022 | $65,578,125 | +74.6% | 173,107 | +62.7% | 0.02% | +70.0% |
Q3 2022 | $37,565,000 | +2.3% | 106,400 | +9.8% | 0.01% | 0.0% |
Q2 2022 | $36,714,000 | +55.9% | 96,900 | +29.7% | 0.01% | +150.0% |
Q1 2022 | $23,553,000 | -52.9% | 74,700 | -47.6% | 0.00% | +300.0% |
Q4 2021 | $49,958,000 | +40.9% | 142,658 | +21.5% | 0.00% | -75.0% |
Q3 2021 | $35,455,000 | +10.3% | 117,400 | +9.9% | 0.00% | 0.0% |
Q2 2021 | $32,155,000 | +8.9% | 106,800 | -0.4% | 0.00% | -20.0% |
Q1 2021 | $29,522,000 | -58.2% | 107,200 | -55.4% | 0.01% | -16.7% |
Q4 2020 | $70,662,000 | +86.1% | 240,274 | +66.2% | 0.01% | -25.0% |
Q3 2020 | $37,960,000 | -18.7% | 144,600 | -30.2% | 0.01% | -33.3% |
Q2 2020 | $46,677,000 | +28.3% | 207,237 | -24.9% | 0.01% | +9.1% |
Q1 2020 | $36,373,000 | +220.5% | 276,117 | +290.5% | 0.01% | +266.7% |
Q4 2019 | $11,349,000 | +36.5% | 70,700 | -3.1% | 0.00% | +50.0% |
Q3 2019 | $8,315,000 | -84.4% | 72,969 | -80.6% | 0.00% | -71.4% |
Q2 2019 | $53,146,000 | +1179.1% | 375,392 | +1028.0% | 0.01% | +600.0% |
Q1 2019 | $4,155,000 | +67.9% | 33,279 | +29.2% | 0.00% | – |
Q4 2018 | $2,474,000 | -49.7% | 25,753 | -60.3% | 0.00% | -100.0% |
Q3 2018 | $4,919,000 | – | 64,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |